This thesis describes a series of experiments in human observers using neurophysiological and behavioural approaches to investigate the effects of varying haptic stimuli, attentional demand and age on motor control and perception during haptic sensing (i.e., using the hand to seek sensory information by touch). In Experiments I-IV, transcranial magnetic stimulation (TMS) was used to explore changes in corticomotor excitability when participants were actively engaged in haptic sensing tasks. These studies showed that corticospinal excitability, as reflected in motor evoked potential (MEP) amplitude, was greatly enhanced when participants were engaged in different forms of haptic sensing. Interestingly, this extra corticomotor facilitation was absent when participants performed finger movements without haptic sensing or when attention was diverted away from haptic input by a concurrent cognitive task (Exp I). This provided strong evidence that the observed corticomotor facilitation was likely central in origin and related to haptic attention. Neuroimaging has shown activation of the parieto-frontal network likely subserves this aspect of haptic perception. Further, this haptic-specific corticomotor facilitation was finely modulated depending on whether participants focused attention on identifying material (texture) as opposed to geometric properties of scanned surfaces (Exp II). With regards to aging effects, haptic-related corticomotor facilitation was associated with higher recognition accuracy in seniors (Exp III). In line with this, seniors exhibited similar levels of haptic-related corticomotor facilitation to young adults when task demands were adjusted for age (Exp IV). Interestingly, both young and senior adults also showed substantial corticomotor facilitation in the ‘resting’ hand when the ipsilateral hand was engaged in haptic sensing (Exp IV). Simply touching the stimulus without being required to identify its properties (no attentional task demands) produced no extra corticomotor facilitation in either hand or age group, attesting again to the specificity of the effects with regards to haptic attention. In Experiments V-VI, the ability to recognise 2-D letters by touch was investigated using kinematic and psychophysical measures. In Experiment V, we characterized how age affected contact forces deployed at the fingertip. This investigation showed that older adults exhibited lower normal force and increased letter-to-letter variability in normal force when compared to young adults. This difference in contact force likely contributed to longer contact times and lower recognition accuracy in older adults, suggesting a central contribution to age-related declines in haptic perception. Consistent with this interpretation, Experiment VI showed that haptic letter recognition in older adults was characterized not only by lower recognition accuracy but also by substantial increases in response times and specific patterns of confusion between letters. All in all, these investigations highlight the critical interaction of central factors such as attentional demand with aging effects on motor and perceptual aspects of haptic sensing. Of particular significance is the clear demonstration that corticomotor excitability is greatly enhanced when a haptic sensing component (i.e., attending to specific haptic features) is added to simple finger movements performed at minimal voluntary effort levels (typically <15 % of the maximal effort). These observations underline the therapeutic potential of active sensory training strategies based on haptic sensing tasks for the re-education of motor and perceptual deficits in hand function (e.g., subsequent to a stroke). The importance of adjusting attentional demands and stimuli is highlighted, particularly with regards to special considerations in the aging population.

No description available.

Basierend auf der aktuellen Studienlage wurde versucht, Modellannahmen zum auditi- ven Sprachverständnisses weiter zu ergründen. Im Mittelpunkt stand dabei die Rolle des Gyrus angularis der sprachdominanten Hemisphäre bei der semantischen Integration von Worten in einen gegebenen Satzkontext. Zu diesem Zweck wurden 15 gesunde Proban- den mithilfe von repetitiver transkranieller Magnetstimulation (rTMS) in einem Sprach- verständnisexperiment untersucht. So konnte die funktionelle Relevanz der genannten Hirnregion in Abhängigkeit der Signalqualität des gehörten Satzes und des semanti- schen Kontextes untersucht werden. Zielparameter waren dabei der Anteil der korrekt wiederholten Wörter und Schlüsselwörter des Satzes sowie die Reaktionsgeschwindigkeit.

We humans are visual creatures, constantly extracting information from the world around us. The source of our ability to understand the visual world is an intricate arrangement of multiple areas in our brains: the visual system. It enables us to recognize our friends and family in diverse conditions, to focus our attention on important aspects of a scene and performs invariant object categorization on multiple levels of abstraction. Vision has been in the focus of scientific interest for many decades and yet our knowledge of the cortical mechanisms involved is only limited. I here describe a series of experiments, in which we investigated how the visual system robustly and efficiently extracts meaning from the environment. In particular, I will focus on thee aspects of object recognition: sampling the environment, visual invariance, and categorization and plasticity. Starting with the selection of visual information, three eyetracking experiments are described in which we investigate the interplay of overt visual attention and object recognition. We show that overt visual attention and object recognition exert a bi-directional influence on each other. Whereas initial patterns of overt visual attention causally affect the outcome of the later recognition, briefly presented contextual information leads to substantial changes in the attentional sampling behavior, which can be best understood in terms of a shifting exploration-exploitation bias. Following this, we turn to visual processing within the system and ask how invariant object recognition is accomplished despite large variation in retinal input. As an exemplary case, we focus on changes introduced by rotations in depth. Using a variety of techniques, ranging from fMRI to TMS and EEG, we show that viewpoint symmetry, i.e. the selectivity to mirror-symmetric viewing angles, is a prevalent feature of visual processing across a wide range of higher-level visual regions. These findings jointly suggest that viewpoint-symmetry constitutes a key computational step in achieving full viewpoint invariance. On the next level of abstraction, we investigate how visual categories are represented at different levels of experience, from novice to expert. By combining training of novel visual categories with psychophysical measures, we demonstrate a change in the underlying type of category representation. Following this, we combine the training paradigm with electrophysiological measurements. In line with our behavioral results, these data reveal a spatiotemporal shift in category selectivity: from late and frontal to early occipitotemporal activity. These results suggest that novel and re-occurring categories rely on partially separate cortical networks, allowing the brain to balance robust and fast recognition with considerable flexibility and plasticity. The results of all experiments presented are unified by the concept of a system that has evolved efficient mechanisms for robust performance in a large variety of conditions. Using dynamic sampling strategies, computational shortcuts and a division of labor, the visual system is optimally equipped to support higher-level cognitive function in a complex and constantly changing environment.

Motion-selectivity in human visual cortex comprises a number of different cortical loci including V1, V2, V3A, V3B, hV5/MT+ and V6 (Wandell et al., 2007). This thesis sought to investigate the specific functions of V3A and sub-divisions of hV5/MT+ (TO-1 and TO-2) by using transcranial magnetic stimulation (TMS) to transiently disrupt cortical activations within these areas during psychophysical tasks of motion perception. The tasks were chosen to coincide with previous non-human primate and human neuroimaging literature; translational, radial and rotational direction discrimination tasks and identification of the position of a focus of expansion. These results assert that TO-1 and TO-2 are functionally distinct subdivisions of hV5/MT+, as we have shown that both TO-1 and TO-2 are responsible for processing translational motion direction whilst only TO-2 is responsible for processing radial motion direction. In ipsilateral space, it was found that TO-1 and TO-2 both contribute to the processing of ipsilateral translational motion. Taken in a wider context, further results also suggested that these areas may form part of a network of cortical areas contributing to perception of self-motion (heading/egomotion), as TO-2 was not found to be responsible for processing the position of the central focus of expansion (imperative for self-direction). Instead, area V3A has been implicated as functionally responsible for processing this attribute of vision. Overall it is clear that TO-1, TO-2 and V3A have specific, distinct functions that contribute towards both parallel and serial motion processing pathways within the human brain. / Life Science Research

Beaucoup de patients atteints de la maladie de Parkinson (MP) peuvent souffrir de troubles cognitifs dès les étapes initiales de la maladie et jusqu’à 80% d’entre eux vont développer une démence. Des altérations fonctionnelles au niveau du cortex préfrontal dorsolatéral (CPFDL), possiblement en relation avec le noyau caudé, seraient à l’origine de certains de ces déficits cognitifs. Des résultats antérieurs de notre groupe ont montré une augmentation de l’activité et de la connectivité dans la boucle cortico-striatale cognitive suite à la stimulation magnétique transcrânienne (SMT) utilisant des paramètres « theta burst » intermittent (iTBS) sur le CPFDL gauche. Pour cette étude, 24 patients atteints de la MP avec des troubles cognitifs ont été séparées en 2 groupes : le groupe iTBS active (N=15) et le groupe sham (stimulation simulée, N=9). Une batterie neuropsychologique détaillée évaluant cinq domaines cognitifs (attention, fonctions exécutives, langage, mémoire et habiletés visuo-spatiales) a été administrée lors des jours 1, 8, 17 et 37. Le protocole iTBS a été appliqué sur le CPFDL gauche durant les jours 2, 4 et 7. Les scores z ont été calculés pour chaque domaine cognitif et pour la cognition globale. Les résultats ont montré une augmentation significative de la cognition globale jusqu’à 10 jours suivant l’iTBS active, particulièrement au niveau de l’attention, des fonctions exécutives et des habiletés visuo-spatiales. Cet effet sur la cognition globale n’est pas répliqué dans le groupe sham. Ces résultats suggèrent donc que l’iTBS peut moduler la performance cognitive chez les patients atteints de MP avec des déficits cognitifs. / Cognitive impairment affects many patients with Parkinson’s disease (PD) in the early phase of the disease and up to 80% of them will eventually develop dementia. Many studies suggests that these cognitive deficits are mediated by functional alterations in the dorsolateral prefrontal cortex (DLPFC), possibly in relation with the caudate nucleus. Previous results from our group showed an increase in activity and connectivity within the cognitive cortico-striatal loop when applying transcranial magnetic stimulation (TMS) using intermittent « theta burst » (iTBS) parameters over left DLPFC. For this study, 24 idiopathic PD patients with cognitive impairment were recruited and divided into two groups : active iTBS group (N=15) and sham group (simulated stimulation, N=9). Detailed neuropsychological assessment of five cognitive domains (attention, executive functions, language, memory, visuospatial abilities) was performed on day 1, 8, 17 and 37. iTBS protocol over left DLPFC was performed on day 2, 4 and 7. Z scores were calculated for each domain and for the overall cognition performance. Our results showed a significant increase in overall cognition up to 10 days after receiving active iTBS, improving mainly attention, executive functions and visuospatial abilities. This effect was not replicated in the sham group. Therefore, our results suggest that iTBS can modulate cognitive performance in PD patients with cognitive deficits.

Novel on-line methods are presented for the extraction, preconcentration and analysis of zwitterionic biomolecules using sol-gel-coated columns coupled to a conventional UV/visible detector. The presented approaches do not require any additional modification of the commercially available standard CE instrument. Extraction, stacking, and focusing techniques were used in the preconcentration procedures. The positively charged sol-gel coatings were created using N-octadecyldimethyl[3-(trimethoxysilyl) proply]ammonium chloride (C18-TMS) in the coating sol solutions. Due to the presence of a positively charged quaternary ammonium moiety in C18-TMS, the resulting sol-gel coating carried a positive charge. The negatively charged sol-gel coatings were due to the presence of sulfonate groups, which was formed from the oxidation of thiol groups in precursor mercaptopropyltrimethoxysilane (MPTMS) by hydrogen peroxide. Besides MPTMS, tetramethoxysilane (TMOS) and n-octadecyltriethoxysilane (C18-TEOS) were also used to prepare the sol solution for the creation of the negatively charged coatings. For extraction, the pH of the samples was properly adjusted to impart a net charge opposite to the sol-gel coatings. When a long plug of the sample was passed through the sol-gel-coated capillary, extraction was achieved via electrostatic interaction between the charged sol-gel coating and the charged sample molecules. The extracted analytes were then desorbed and focused via local pH change and stacking. The local pH change was accomplished by passing buffer solutions with proper pH values, while a dynamic pH junction between the sample solution and the background electrolyte was utilized to facilitate solute focusing. The developed methods showed excellent extraction and preconcentration effects on both positively and negatively charged sol-gel-coated columns. On-line preconcentration and analysis results obtained on the sol-gel coated columns were compared with those obtained on an uncoated fused silica capillary of identical dimensions using conventional sample injections. The described procedure provided a 150 000-fold enrichment effect for alanine on the positively charged sol-gel-coated column. On the negatively charged sol-gel-coated column, the presented sample preconcentration technique provided a sensitivity enhancement factor (SEF) on the order of 3 x 103 for myoglobin, and 7 x 103 for asparagines. The developed methods provided acceptable repeatability in terms of both peak height and migration time.

Being able to generate predictions about what is going to happen next while observing other people’s actions plays a crucial role in our daily lives. Different theoretical explanations for the underlying processes of humans’ action prediction abilities have been suggested. Whereas an embodied account posits that predictive gaze relies on embodied simulations in the observer’s motor system, other accounts do not assume a causal role of the motor system for action prediction. The general aim of this thesis was to augment current knowledge about the functional mechanisms behind humans’ action prediction abilities. In particular, the present thesis outlines and tests an embodied account of action prediction. The second aim of this thesis was to extend prior action prediction studies by exploring infants’ online gaze during observation of social interactions. The thesis reports 3 eye-tracking studies that were designed to measure adults’ and infants’ predictive eye movements during observation of different manual and social actions. The first two studies used point-light displays of manual reaching actions as stimuli to isolate human motion information. Additionally, Study II used transcranial magnetic stimulation (TMS) to directly modify motor cortex activity. Study I showed that kinematic information from biological motion can be used to anticipate the goal of other people’s point-light actions and that the presence of biological motion is sufficient for anticipation to occur. Study II demonstrated that TMS-induced temporary lesions in the primary motor cortex selectively affected observers’ gaze latencies. Study III examined 12-month-olds’ online gaze during observation of a give-and-take interaction between two individuals. The third study showed that already at one year of age infants shift their gaze from a passing hand to a receiving hand faster when the receiving hand forms a give-me gesture compared to an inverted hand shape. The reported results from this thesis make two major contributions. First, Studies I and II provide evidence for an embodied account of action prediction by demonstrating a direct connection between anticipatory eye movements and motor cortex activity. These findings support the interpretation that predictive eye movements are driven by a recruitment of the observer’s own motor system. Second, Study III implicates that properties of social action goals influence infants’ online gaze during action observation. It further suggests that at one year of age infants begin to show sensitivity to social goals within the context of give-and-take interactions while observing from a third-party perspective.

Introdução: A neuroplasticidade é um processo dinâmico e contínuo. Estruturas cerebrais e vias neurais participam de maneira conexa e intrincada no processo nociceptivo e nos seus mecanismos neuromodulatórios, tanto na sinalização quanto no desencadeamento de modificações anátomo-funcionais. Com o advento de técnicas de estimulação transcraniana não invasiva, como a estimulação transcraniana por corrente contínua (tDCS) que tem se revelado uma possibilidade terapêutica não farmacológica para o tratamento da dor, associada à melatonina, fármaco que tem demonstrado ação analgésica, o racional deste estudo é a pressuposição que o uso combinado dessas duas intervenções poderia ter efeito sinérgico ou aditivo no processamento nociceptivo. Foram avaliados parâmetros neurofisiológicos da excitabilidade cortical dados pela estimulação magnética transcraniana (TMS), pela dosagem do fator neurotrófico derivado do cérebro (BDNF) e pelo teste de quantificação sensitiva (QST). Objetivos: Com o intuito de compreender o processo neuroplástico do sistema nociceptivo o presente trabalho tem dois objetivos: 1) Determinar a relação entre os níveis séricos do BDNF e a resposta à dor aguda induzida experimentalmente, assim como avaliar os substratos neurais dessa relação por meio da estimulação magnética transcraniana (TMS) e da função do sistema modulador descendente durante o estímulo condicionado pela tarefa (CPM-TASK); 2) Avaliar o efeito da melatonina isolada ou combinada à tDCS no limiar de dor ao calor, no CPM-TASK, nos parâmetros de excitabilidade cortical e nos níveis de BDNF em sujeitos saudáveis. Pacientes e métodos: Foram recrutados 20 sujeitos saudáveis masculinos, com idade entre 18 e 40 anos, em um ensaio clínico randomizado, crossover, placebo-controlado, cujo processo de randomização foi 2:2:1, favorendo os grupos de tratamentos ativos, divididos em 3 grupos: melatonina+tDCS ativo (n=20); melatonina+tDCS-sham (n=20) e placebo+tDCS-sham (n=10). Realizado coleta de sangue, parâmetros de excitabilidade cortical com o limiar motor (LM), potencial evocado motor (MEP), facilitação intracortical (FIC), inibição intracortical (IIC), e teste de quantificação sensitiva (QST) e CPM-TASK mensurados por escala numérica (NPS (0-10)) durante o estímulo algogênico induzido pelo calor (HPT), em avaliações basais e após os tratamentos propostos. A estimulação com a tDCS anódica foi aplicada sobre o córtex motor primário (M1), durante 20 minutos, com corrente de 2 mA, em única sessão. A melatonina foi administrada por via sublingual na dose de 0,25 mg/kg (máximo de 20mg). Resultados: Os resultados mostram que o limiar de dor ao calor (HPT) em graus Celsius (°C) está inversamente correlacionado com o BDNF sérico [Beta= -0.09, P=0.03], escores da NPS(0-10) durante CPM-TASK [Beta= -0.08, P=0.04)] e a facilitação intracortical [Beta= - 1.11, P=0.01]. Em relação ao ensaio clínico o efeito do tratamento determinou diferença significativa no limiar de dor ao calor, cuja diferença na média foi 4.86 [intervalo de confiança (IC), 95% (0.9 a 8.63)] quando comparado o grupo melatonina+tDCS ativo com o placebo+tDCS-sham. A diferença na média foi de 5.16 [(IC) 95% (0.84 a 8.36] quando comparado o grupo melatonina+tDCS-Sham com o grupo placebo+tDCS-sham. A diferença na média entre os grupos melatonina+tDCS ativo com melatonina+tDCS-Sham foi 0.29 [(CI) 95% = -3.72 a 4.23]. A diferença na média entre os grupos melatonina+tDCS ativo versus placebo+tDCS-sham no MEP foi de -20,37[(CI) 95% (-39,68 a -1,2)]. Não se observou diferença estatisticamente significativa entre os grupos nos demais parâmetros de excitabilidade cortical, no sistema modulador descendente (SMD) da dor avaliado pela CPMTASK ou nos níveis séricos de BDNF. Conclusões: Estes achados apoiam a hipótese de que o limiar de dor (HPT) está correlacionado de maneira inversa com o BDNF sérico e o nível de FIC, assim como a potência do sistema modulador descendente mostrou relação inversa com os níveis séricos de BDNF. Também, no contexto de dor aguda experimental a tDCS associada à melatonina não exerceu efeito sinérgico ou aditivo no limiar de dor ao calor. O tratamento combinado não mudou a função do sistema modulador descendente, nem os níveis séricos de BDNF. Estes achados sugerem que a ação da melatonina não é mediada por fatores em níveis cortical ou medular, pelo fato de não mudar a excitabilidade cortical, nem a dor ao estímulo condicionado pela tarefa. / Background: Pain-induced neuronal plasticity involves multiple molecular interactions. Transcranial direct current stimulation (tDCS) is a non-invasive method of brain stimulation has been used to address a variety pain conditions. Melatonin, new therapies pharmacological, used in different therapeutic as analgesic, anti-inflammatory and sedative effects. Interesting question is if their combination could result in additive or synergistic effect on cortical excitability measurements via transcranial stimulation parameters (TMS), pain threshold determined by quantitative sensory testing (QST) and BDNF serum levels. Objective: 1) Determine the relationship between BDNF serum levels and acute experimental pain response, neural substrates of this relationship by assessing transcranial magnetic stimulation (TMS)-indexed cortical excitability and descending inhibitory response [Conditioned Pain Modulation, (CPM)] during CPM-TASK. 2) To test the effects combined intervention transcranial direct current stimulation (tDCS) and melatonin on pain was assessed by quantitative and sensory testing and the conditional pain modulation (CPM) during CPM-TASK, cortical excitability, as assessed by transcranial magnetic stimulation (TMS), and on serum brain-derived neurotrophic factor (BDNF) level. METHODS: We enrolled 20 healthy males aged 18 to 40 years in a blinded, placebocontrolled, crossover, randomized clinical trial. They were divided into three groups: sublingual melatonin (0.25 mg/kg)+active-tDCS (n = 20), melatonin (0.25 mg/kg)+shamtDCS (n = 20), or sublingual placebo+sham-tDCS (n = 10). One session of anodal stimulation (2 mA, 20 min) was applied over the primary motor cortex. Blood sample was collected and cortical excitability parameters were determined by TMS, followed by psychophysical pain testing and descending inhibitory response [Conditioned Pain Modulation, (CPM)] during CPM-TASK. Results: Heat pain threshold (HPT) was inversely correlated with BDNF levels [Beta=-0.09, P=0.03)] and Intracortical Facilitation (ICF) (Beta=-1.11, P=0.01) and the efficiency of the descending pain inhibitory system (as indexed by CPM, Beta=- 1.11, P=0.04) was inversely correlated with BDNF levels. There was a significant difference in the heat pain threshold (°C) for melatonin+active-tDCS (mean difference: 4.86, 95% confidence interval [CI]: 0.9 to 8.63) and placebo+sham-tDCS (mean: 5.16, 95% CI: 0.84 to 8.36). There was no difference between melatonin+active-tDCS and melatonin+sham-tDCS (mean difference: 0.29, 95% CI: −3.72 to 4.23). Melatonin alone did not significantly affect cortical excitability, CPM task result, or serum BDNF level. Conclusions: These findings support that serum neuroplasticity mediators have an association with the cortical excitability pattern and its response to acute experimental pain in healthy males, clinically supporting the existence of a role in the pain modulation process which is possibly involved in the descending pain inhibitory system. Also findings support the beneficial effects of melatonin on acute experimental pain; however, its association with active-tDCS did not increase its effectiveness. Melatonin’s effects are likely not mediated by cortical or spinal centers given the lack of effects on cortical excitability and on the CPM task.

Introdução: A neuroplasticidade é um processo dinâmico e contínuo. Estruturas cerebrais e vias neurais participam de maneira conexa e intrincada no processo nociceptivo e nos seus mecanismos neuromodulatórios, tanto na sinalização quanto no desencadeamento de modificações anátomo-funcionais. Com o advento de técnicas de estimulação transcraniana não invasiva, como a estimulação transcraniana por corrente contínua (tDCS) que tem se revelado uma possibilidade terapêutica não farmacológica para o tratamento da dor, associada à melatonina, fármaco que tem demonstrado ação analgésica, o racional deste estudo é a pressuposição que o uso combinado dessas duas intervenções poderia ter efeito sinérgico ou aditivo no processamento nociceptivo. Foram avaliados parâmetros neurofisiológicos da excitabilidade cortical dados pela estimulação magnética transcraniana (TMS), pela dosagem do fator neurotrófico derivado do cérebro (BDNF) e pelo teste de quantificação sensitiva (QST). Objetivos: Com o intuito de compreender o processo neuroplástico do sistema nociceptivo o presente trabalho tem dois objetivos: 1) Determinar a relação entre os níveis séricos do BDNF e a resposta à dor aguda induzida experimentalmente, assim como avaliar os substratos neurais dessa relação por meio da estimulação magnética transcraniana (TMS) e da função do sistema modulador descendente durante o estímulo condicionado pela tarefa (CPM-TASK); 2) Avaliar o efeito da melatonina isolada ou combinada à tDCS no limiar de dor ao calor, no CPM-TASK, nos parâmetros de excitabilidade cortical e nos níveis de BDNF em sujeitos saudáveis. Pacientes e métodos: Foram recrutados 20 sujeitos saudáveis masculinos, com idade entre 18 e 40 anos, em um ensaio clínico randomizado, crossover, placebo-controlado, cujo processo de randomização foi 2:2:1, favorendo os grupos de tratamentos ativos, divididos em 3 grupos: melatonina+tDCS ativo (n=20); melatonina+tDCS-sham (n=20) e placebo+tDCS-sham (n=10). Realizado coleta de sangue, parâmetros de excitabilidade cortical com o limiar motor (LM), potencial evocado motor (MEP), facilitação intracortical (FIC), inibição intracortical (IIC), e teste de quantificação sensitiva (QST) e CPM-TASK mensurados por escala numérica (NPS (0-10)) durante o estímulo algogênico induzido pelo calor (HPT), em avaliações basais e após os tratamentos propostos. A estimulação com a tDCS anódica foi aplicada sobre o córtex motor primário (M1), durante 20 minutos, com corrente de 2 mA, em única sessão. A melatonina foi administrada por via sublingual na dose de 0,25 mg/kg (máximo de 20mg). Resultados: Os resultados mostram que o limiar de dor ao calor (HPT) em graus Celsius (°C) está inversamente correlacionado com o BDNF sérico [Beta= -0.09, P=0.03], escores da NPS(0-10) durante CPM-TASK [Beta= -0.08, P=0.04)] e a facilitação intracortical [Beta= - 1.11, P=0.01]. Em relação ao ensaio clínico o efeito do tratamento determinou diferença significativa no limiar de dor ao calor, cuja diferença na média foi 4.86 [intervalo de confiança (IC), 95% (0.9 a 8.63)] quando comparado o grupo melatonina+tDCS ativo com o placebo+tDCS-sham. A diferença na média foi de 5.16 [(IC) 95% (0.84 a 8.36] quando comparado o grupo melatonina+tDCS-Sham com o grupo placebo+tDCS-sham. A diferença na média entre os grupos melatonina+tDCS ativo com melatonina+tDCS-Sham foi 0.29 [(CI) 95% = -3.72 a 4.23]. A diferença na média entre os grupos melatonina+tDCS ativo versus placebo+tDCS-sham no MEP foi de -20,37[(CI) 95% (-39,68 a -1,2)]. Não se observou diferença estatisticamente significativa entre os grupos nos demais parâmetros de excitabilidade cortical, no sistema modulador descendente (SMD) da dor avaliado pela CPMTASK ou nos níveis séricos de BDNF. Conclusões: Estes achados apoiam a hipótese de que o limiar de dor (HPT) está correlacionado de maneira inversa com o BDNF sérico e o nível de FIC, assim como a potência do sistema modulador descendente mostrou relação inversa com os níveis séricos de BDNF. Também, no contexto de dor aguda experimental a tDCS associada à melatonina não exerceu efeito sinérgico ou aditivo no limiar de dor ao calor. O tratamento combinado não mudou a função do sistema modulador descendente, nem os níveis séricos de BDNF. Estes achados sugerem que a ação da melatonina não é mediada por fatores em níveis cortical ou medular, pelo fato de não mudar a excitabilidade cortical, nem a dor ao estímulo condicionado pela tarefa. / Background: Pain-induced neuronal plasticity involves multiple molecular interactions. Transcranial direct current stimulation (tDCS) is a non-invasive method of brain stimulation has been used to address a variety pain conditions. Melatonin, new therapies pharmacological, used in different therapeutic as analgesic, anti-inflammatory and sedative effects. Interesting question is if their combination could result in additive or synergistic effect on cortical excitability measurements via transcranial stimulation parameters (TMS), pain threshold determined by quantitative sensory testing (QST) and BDNF serum levels. Objective: 1) Determine the relationship between BDNF serum levels and acute experimental pain response, neural substrates of this relationship by assessing transcranial magnetic stimulation (TMS)-indexed cortical excitability and descending inhibitory response [Conditioned Pain Modulation, (CPM)] during CPM-TASK. 2) To test the effects combined intervention transcranial direct current stimulation (tDCS) and melatonin on pain was assessed by quantitative and sensory testing and the conditional pain modulation (CPM) during CPM-TASK, cortical excitability, as assessed by transcranial magnetic stimulation (TMS), and on serum brain-derived neurotrophic factor (BDNF) level. METHODS: We enrolled 20 healthy males aged 18 to 40 years in a blinded, placebocontrolled, crossover, randomized clinical trial. They were divided into three groups: sublingual melatonin (0.25 mg/kg)+active-tDCS (n = 20), melatonin (0.25 mg/kg)+shamtDCS (n = 20), or sublingual placebo+sham-tDCS (n = 10). One session of anodal stimulation (2 mA, 20 min) was applied over the primary motor cortex. Blood sample was collected and cortical excitability parameters were determined by TMS, followed by psychophysical pain testing and descending inhibitory response [Conditioned Pain Modulation, (CPM)] during CPM-TASK. Results: Heat pain threshold (HPT) was inversely correlated with BDNF levels [Beta=-0.09, P=0.03)] and Intracortical Facilitation (ICF) (Beta=-1.11, P=0.01) and the efficiency of the descending pain inhibitory system (as indexed by CPM, Beta=- 1.11, P=0.04) was inversely correlated with BDNF levels. There was a significant difference in the heat pain threshold (°C) for melatonin+active-tDCS (mean difference: 4.86, 95% confidence interval [CI]: 0.9 to 8.63) and placebo+sham-tDCS (mean: 5.16, 95% CI: 0.84 to 8.36). There was no difference between melatonin+active-tDCS and melatonin+sham-tDCS (mean difference: 0.29, 95% CI: −3.72 to 4.23). Melatonin alone did not significantly affect cortical excitability, CPM task result, or serum BDNF level. Conclusions: These findings support that serum neuroplasticity mediators have an association with the cortical excitability pattern and its response to acute experimental pain in healthy males, clinically supporting the existence of a role in the pain modulation process which is possibly involved in the descending pain inhibitory system. Also findings support the beneficial effects of melatonin on acute experimental pain; however, its association with active-tDCS did not increase its effectiveness. Melatonin’s effects are likely not mediated by cortical or spinal centers given the lack of effects on cortical excitability and on the CPM task.